Community

Kiren Khanduga

Associate Director in the CMC Group, Pionyr Immunotherapeutics

Kiren Khanduja is an Associate Director in the CMC Group at Pionyr Immunotherapeutics, and has over 10 years of experience working in the biotechnology industry. She joined Pionyr in December 2019 and manages outsourced development and manufacturing activities across various Contract Development and Manufacturing Organizations (CDMOs) for both Drug Substance and Drug Product. Kiren played a key role in establishing the company’s relationship with Lonza. Prior to Pionyr, Kiren worked on the CDMO side of the business at Boehringer Ingelheim, supporting late-stage clients. Kiren earned an B.S./M.S.E. in Chemical Engineering from Johns Hopkins University.

Community

Kiren Khanduga

Associate Director in the CMC Group, Pionyr Immunotherapeutics

Contributions

Tuning the Myeloid Compartment with a Best-in-Class CDMO